OR
Orion Pharma
ORNAV.HE·OMXEspoo FIFounded 19173,500 employees
Mid CappharmaPublicOncologyCNS
Platform: Darolutamide
Market Cap
$4B
All Drugs
3
Clinical Trials
5
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (ORNAV.HE)
Loading ORNAV.HE stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| ORN-2989 | ORN-2989 | Phase 1 | 2 | Aβ | MyelofibrosisDMD | ||
| Teraosocimab | ORN-7476 | Phase 1 | 1 | EZH2 | FL | ||
| Doxazasiran | ORN-6585 | Phase 1 | 2 | EGFR | Breast Ca |
SEC Filings & Financial Documents
SEC filings are not available for OMX-listed companies.
Orion Pharma trades on OMX (FI). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (5)